Investor

Pharmstandard

Last cheque observed Dec 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietCorporate VC

Series BSeries DSeries EBiotechnologyManufacturingPharmaceutical

Cheques on record
0%of best year0cheques in 12 months, 8 on record
Since the last cheque3241days00hrs00min00sec
Median round$21MRounds led0 of 8Sole investor1 roundsMostly inUnited States, 75%
Pitch Pharmstandard

Pharmstandard highlights

  1. 01

    8 rounds on record

  2. 02

    Mostly Series B and Series D: 86% of its rounds

  3. 03

    Sole investor in 1 rounds, median $4.0M

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyManufacturingPharmaceutical
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2017

    2 rounds

  2. Dec
    OncoTartisUS · FinSMEs$6.0MWith 1 other
  3. Dec
    Neon TherapeuticsSeries B · US · FinSMEs$36MWith 8 others
  4. 2015

    2 rounds

  5. Apr
    Jounce TherapeuticsSeries B · US$56MWith 7 others
  6. Jan
    enGeneSeries B · CA$12MWith 2 others
  7. 2014

    2 rounds

  8. Dec
    Allena PharmaceuticalsSeries B · US$25MWith 4 others
  9. May
    Proteon TherapeuticsSeries D · US$45MWith 9 others
  10. 2013

    2 rounds

  11. Sept
    Protagonist TherapeuticsSeries B · AU · pevc.dowjones.com$4.0MSole investor
  12. Aug
    Argos TherapeuticsSeries E · US · finsmes.com$43MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

What they claim to have backed

From their own portfolio page (on their website)

0 of 2 we have independently watched raise

Disclosure of informationPh2014

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as Pharmstandard. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Pharmstandard

What does Pharmstandard invest in?

Pharmstandard invests most often at Series B and Series D (86% of the rounds on record), in sectors such as Biotechnology, Manufacturing and Pharmaceutical.

How active is Pharmstandard?

8 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2017.

What has Pharmstandard invested in recently?

Its most recent investments on record: OncoTartis (Undisclosed round, Dec 2017) and Neon Therapeutics (Series B, Dec 2017).

How big are Pharmstandard's cheques?

The median round it joins is $21M.

Does Pharmstandard lead rounds?

Rarely, if at all: none of its 8 investments on record names it as the lead.

Where does Pharmstandard invest?

Most of the companies it backs are in the United States (75%), Canada (13%) and Australia (13%).

Is Pharmstandard investing now?

No investments in the last 12 months; the latest was in Dec 2017.

Who does Pharmstandard invest alongside?

Most often Bessemer Venture Partners (2 rounds together), Casdin Capital (2 rounds together) and Intersouth Partners (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it